Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eiger Biopharma (NQ: EIGR )

10.73 USD +0.18 (+1.71%)
Official Closing Price Updated: 5:26 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Eiger Biopharma

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Mid-Afternoon Market Update: Dow Surges 500 Points; Piedmont Lithium Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 1.85% to 27,676.98 while the NASDAQ rose 1.51% to 11,078.09. The S&P also rose, ... 
Tags Market News CALM Earnings
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares jumped 534.5% to $6.79 after gaining 7% on Friday. Piedmont Lithium ... 
Tags IEA TRMT GLNG
From Benzinga
Mid-Day Market Update: Perceptron Jumps Following Acquisition News; Inovio Pharmaceuticals Shares Plunge
Midway through trading Monday, the Dow traded up 1.59% to 27606.52 while the NASDAQ rose 1.29% to 11,053.88. The S&P also rose, ... 
Tags Earnings CALM Market News
From Benzinga
Eiger Shares Nosedive On COVID-19 Study Results
Shares of micro-cap biopharma Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) were moving sharply to the downside Monday after one of ... 
Tags Market News Biotech Health Care
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Cal-Maine Foods Reports Narrower-Than-Expected Loss
Following the market opening Monday, the Dow traded up 1.28% to 27520.66 while the NASDAQ rose 1.04% to 11027.31. The S&P also rose, ... 
Tags Benzinga Mid/Morning Market Update EIGR
From Benzinga
4 Sectors Moving Down In Monday's Pre-Market Session
Here is the sector-by-sector list of stocks moving lower in today's pre-market session: Healthcare Sun BioPharma ... 
Tags CARV GNUS AQST
From Benzinga
Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced results of an investigator... 
From PR Newswire
Notable Friday Option Activity: MA, IBM, EIGR
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Mastercard Inc (MA), where a total of 18,368 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
The Implied Analyst 12-Month Target For VTHR
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Eiger Bio to Participate in September 2020 Investor Conferences
From PR Newswire
Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress™ 2020
- 96% of Patients Achieve Primary Endpoint of > 2 Log Decline in HDV RNA 
From PR Newswire
The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) 10X Genomics Inc (NASDAQ: TXG) Abbott Laboratories (NYSE: ... 
Tags Biotech Offerings Penny Stocks
From Benzinga
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
After seeing strength earlier, biotech stocks came under pressure in the past week. With the earnings season tapering and not much noise on the coronavirus front, the sector reacted to clinical... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21. With the earnings season tapering ... 
Tags VKTX EDAP XBI
From Benzinga
EIGR Trading Below Director's Recent Buy Price
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 12, Eiger BioPharmaceuticals Inc's Director,... 
Tags Stocks
From Market News Video
IBB's Holdings Imply 20% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial results for... 
From PR Newswire
Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will... 
From PR Newswire
EIGR Makes Bullish Cross Above Critical Moving Average
In trading on Monday, shares of Eiger BioPharmaceuticals Inc (EIGR) crossed above their 200 day moving average of $10.69, changing hands as high as $10.84 per share. Eiger BioPharmaceuticals Inc shares... 
Tags Stocks
From Market News Video
The Math Shows IBB Can Go To $158
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and... 
From PR Newswire
Eiger to Present at Jefferies Virtual Healthcare Conference 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management will... 
From PR Newswire
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA EVOK TBIO
From Benzinga
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and... 
From PR Newswire
How I’m Playing The Red-Hot Small-Cap Biotech Stocks
Government provided liquidity has lifted all boats and removed (most of) the funding risk for dev stage biotechs. At the same time there is a recognition by investors that many biotech firms are not... 
Tags Pharma/Biotech Stocks / Equities ETFs
From Blogs - TalkMarkets
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers • Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) shares moved upwards by 74.85% to $1.09 during Wednesday's pre-market ... 
Tags ACER Healthcare Stocks Pre/Market Movers Trading Ideas
From Benzinga
78 Biggest Movers From Yesterday
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares climbed 66.7% to close at $3.95 on Monday after the company highlighted ... 
Tags ANGI UAA AMAG
From Benzinga
54 Stocks Moving In Monday's Mid-Day Session
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 95% to $4.62 after the company highlighted the publication of an ... 
Tags ACB REPH XHR
From Benzinga
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial results for... 
From PR Newswire
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
- Six International, Investigator Sponsored Studies Initiating and Enrolling 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.